C29H28O5PRe, triclinic, P1̄ (no. 2), a = 12.733(7) Å, b = 18.668(11) Å, c = 24.779(15) Å, α = 101.442(20)°, β = 100.844(18)°, γ = 104.240(19)°, V = 5419(9) Å3, Z = 8, Rgt(F) = 0.0307, wRref(F2) = 0.0772, T = 100 K
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
{Bromo-fac-tricarbonyl-[\h^2^-P,O-(2-\ diisopropylphosphinobenzaldehyde)]-rhenium(I)}is obtained fro...
C43H34NO8PS2Re2, monoclinic, P21/c (no. 14), a = 12.165(8) Å, b = 19.027(11) Å, c = 18.848(14) Å,...
C18H16O3N4Re, monoclinic, P21/c (no. 14), a = 9.8409(6) Å, b = 14.0933(9) Å, c = 13.9153(9) Å, β = 9...
C12H17N2O5ReS2, monoclinic, P21/c (no. 14), a = 11.99393(5) Å, b = 20.48791(11) Å, c = 13.67105(6) Å...
C13H10O6N3Re, monoclinic, P21/c (no. 14), a = 7.9325(9) Å, b = 13.811(2) Å, c = 13.458(2) Å, β = 92....
C15H12Br0.2Cl0.8N2O3Re1, monoclinic, P21/c (no. 14), a = 14.6713(4) Å, b = 11.4724(3) Å, c = 9.6206(...
C32H48NO2PRh, orthorhombic, P212121 (no. 19), a = 26.784(10) Å, b = 8.837(3) Å, c = 12.759(4) Å, V =...
C25H28INO3PRh, monoclinic, P21/c (no. 14), a = 11.339(4) Å, b = 9.887(5) Å, c = 23.069(9) Å, β = 91....
C42H45NO8P2Re2, monoclinic, C2/c (no. 15), a = 24.1612(7) Å, b = 13.0229(3) Å, c = 14.9180(4) Å, β =...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
Crystals of the title compound, fac,cis-[ReBr(C21H21P)2(CO)3], were obtained by recrystallization of...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
{Bromo-fac-tricarbonyl-[\h^2^-P,O-(2-\ diisopropylphosphinobenzaldehyde)]-rhenium(I)}is obtained fro...
C43H34NO8PS2Re2, monoclinic, P21/c (no. 14), a = 12.165(8) Å, b = 19.027(11) Å, c = 18.848(14) Å,...
C18H16O3N4Re, monoclinic, P21/c (no. 14), a = 9.8409(6) Å, b = 14.0933(9) Å, c = 13.9153(9) Å, β = 9...
C12H17N2O5ReS2, monoclinic, P21/c (no. 14), a = 11.99393(5) Å, b = 20.48791(11) Å, c = 13.67105(6) Å...
C13H10O6N3Re, monoclinic, P21/c (no. 14), a = 7.9325(9) Å, b = 13.811(2) Å, c = 13.458(2) Å, β = 92....
C15H12Br0.2Cl0.8N2O3Re1, monoclinic, P21/c (no. 14), a = 14.6713(4) Å, b = 11.4724(3) Å, c = 9.6206(...
C32H48NO2PRh, orthorhombic, P212121 (no. 19), a = 26.784(10) Å, b = 8.837(3) Å, c = 12.759(4) Å, V =...
C25H28INO3PRh, monoclinic, P21/c (no. 14), a = 11.339(4) Å, b = 9.887(5) Å, c = 23.069(9) Å, β = 91....
C42H45NO8P2Re2, monoclinic, C2/c (no. 15), a = 24.1612(7) Å, b = 13.0229(3) Å, c = 14.9180(4) Å, β =...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
Crystals of the title compound, fac,cis-[ReBr(C21H21P)2(CO)3], were obtained by recrystallization of...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
trans-Bis(triphenylphosphine)dicarbonyl(1,3-di-p-tolyltriazenido)rhenium(I) crystd. in triclinic spa...
{Bromo-fac-tricarbonyl-[\h^2^-P,O-(2-\ diisopropylphosphinobenzaldehyde)]-rhenium(I)}is obtained fro...
C43H34NO8PS2Re2, monoclinic, P21/c (no. 14), a = 12.165(8) Å, b = 19.027(11) Å, c = 18.848(14) Å,...